Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COCH Envoy Medical	$1.15 -2.5%	$1.48	$1.13 ▼ $3.99	$24.75M	2.21	697,260 shs	208,770 shs
RVP Retractable Technologies	$0.83 -0.9%	$0.71	$0.56 ▼ $0.99	$24.76M	1.15	59,025 shs	208,955 shs
SINT Sintx Technologies	$3.49 +7.1%	$3.02	$1.71 ▼ $8.60	$9.63M	0.65	48,611 shs	125,270 shs
VVOS Vivos Therapeutics	$4.20 -8.7%	$4.52	$1.98 ▼ $7.95	$31.52M	7.03	177,701 shs	163,316 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COCH Envoy Medical	-2.54%	-19.01%	-28.13%	-31.91%	-60.34%
RVP Retractable Technologies	-0.93%	+4.00%	+19.41%	+27.43%	-13.85%
SINT Sintx Technologies	+7.06%	+14.80%	+26.91%	+29.74%	-26.37%
VVOS Vivos Therapeutics	-8.70%	+2.19%	-25.13%	+84.21%	+48.05%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COCH Envoy Medical	3.0444 of 5 stars	3.5	5.0	0.9	3.3	0.0
RVP Retractable Technologies	1.8413 of 5 stars	0.0	3.0	3.4	3.3	0.6
SINT Sintx Technologies	2.1274 of 5 stars	3.5	4.0	0.6	1.7	0.0
VVOS Vivos Therapeutics	1.299 of 5 stars	2.3	4.0	1.6	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COCH Envoy Medical	3.00	Buy	$9.25	704.35% Upside
RVP Retractable Technologies	0.00	N/A	N/A	N/A
SINT Sintx Technologies	3.00	Buy	$28.00	702.29% Upside
VVOS Vivos Therapeutics	2.50	Moderate Buy	$4.82	14.68% Upside

Current Analyst Ratings Breakdown

Latest SINT, COCH, VVOS, and RVP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/30/2025	SINT Sintx Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$30.00 ➝ $28.00
5/27/2025	COCH Envoy Medical	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$9.25 ➝ $9.50

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COCH Envoy Medical	$220K	112.49	N/A	N/A	($1.39) per share	-0.83
RVP Retractable Technologies	$38.16M	0.65	$0.02 per share	48.25	$3.31 per share	0.25
SINT Sintx Technologies	$2.89M	3.33	N/A	N/A	$1.45 per share	2.41
VVOS Vivos Therapeutics	$15.03M	2.10	N/A	N/A	$0.61 per share	6.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COCH Envoy Medical	-$20.80M	-$1.43	N/A	N/A	N/A	-10,961.26%	N/A	-236.14%	N/A
RVP Retractable Technologies	-$7.01M	-$0.29	N/A	∞	N/A	-41.11%	-17.15%	-9.33%	N/A
SINT Sintx Technologies	-$11.02M	-$50.56	N/A	∞	N/A	-674.05%	-256.59%	-121.32%	11/11/2025 (Estimated)
VVOS Vivos Therapeutics	-$11.14M	-$1.68	N/A	N/A	N/A	-99.49%	-232.76%	-84.30%	N/A

Latest SINT, COCH, VVOS, and RVP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2025	Q2 2025	VVOS Vivos Therapeutics	-$0.39	-$0.55	-$0.16	-$0.55	$3.37 million	$3.82 million
8/14/2025	Q2 2025	SINT Sintx Technologies	-$0.79	-$0.91	-$0.12	-$0.91	$0.40 million	$0.15 million
7/31/2025	Q2 2025	COCH Envoy Medical	-$0.29	-$0.32	-$0.03	-$0.32	$0.07 million	$0.08 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
RVP Retractable Technologies	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COCH Envoy Medical	N/A	0.94	0.74
RVP Retractable Technologies	0.01	8.57	5.92
SINT Sintx Technologies	N/A	2.57	3.25
VVOS Vivos Therapeutics	1.69	1.05	0.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
COCH Envoy Medical	8.59%
RVP Retractable Technologies	7.58%
SINT Sintx Technologies	18.38%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
COCH Envoy Medical	58.90%
RVP Retractable Technologies	57.10%
SINT Sintx Technologies	4.08%
VVOS Vivos Therapeutics	3.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
COCH Envoy Medical	34	21.52 million	8.85 million	Not Optionable
RVP Retractable Technologies	240	29.94 million	13.47 million	Optionable
SINT Sintx Technologies	40	2.76 million	2.65 million	Not Optionable
VVOS Vivos Therapeutics	160	7.50 million	7.28 million	Optionable

SINT, COCH, VVOS, and RVP Headlines

Recent News About These Companies

Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript

August 22 at 4:05 PM | seekingalpha.com

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2025 Earnings Call Transcript

August 21 at 8:51 AM | msn.com

Vivos Reports 7% Sales Drop

August 21 at 3:50 AM | aol.comA

Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

August 20 at 5:34 AM | finanznachrichten.de

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

August 19, 2025 | globenewswire.com

Vivos Therapeutics, Inc. Announces Upcoming Release of Second Quarter 2025 Financial Results and Conference Call

August 19, 2025 | quiverquant.comQ

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

August 19, 2025 | globenewswire.com

Vivos Therapeutics Delays Q2 2025 10-Q Filing

August 14, 2025 | msn.com

Vivos Therapeutics Adds to Management Team to Support Expansion and Growth

July 30, 2025 | finance.yahoo.com

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance - Morningstar

July 2, 2025 | morningstar.comM

Vivos Therapeutics Inc. (VVOS) Stock Price Today - WSJ

July 2, 2025 | wsj.com

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance

July 1, 2025 | taiwannews.com.twT

Vivos Therapeutics stock soars after Medicare approves VidaSleep oral appliance

July 1, 2025 | in.investing.com

Vivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral Device

July 1, 2025 | msn.com

Vivos Therapeutics Secures CMS Approval for VidaSleep™ Oral Appliance, Expanding Access to Sleep Apnea Treatment

July 1, 2025 | quiverquant.comQ

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26, 2025 | finance.yahoo.com

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26, 2025 | globenewswire.com

Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finanznachrichten.de

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finance.yahoo.com

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada, Expanding OSA Diagnostic and Treatment Capabilities

June 11, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT, COCH, VVOS, and RVP Company Descriptions

Envoy Medical NASDAQ:COCH

$1.15 -0.03 (-2.54%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.15 0.00 (-0.35%)

As of 08/22/2025 07:35 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Retractable Technologies NYSE:RVP

$0.83 0.00 (-0.57%)

As of 08/22/2025 04:00 PM Eastern

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Sintx Technologies NASDAQ:SINT

$3.49 +0.23 (+7.06%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$3.38 -0.11 (-3.12%)

As of 08/22/2025 07:55 PM Eastern

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Vivos Therapeutics NASDAQ:VVOS

$4.20 -0.40 (-8.70%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$4.22 +0.02 (+0.48%)

As of 08/22/2025 07:59 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time